AssetMark Inc’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-273
Closed -$14.4K 1803
2023
Q2
$14.4K Sell
273
-486
-64% -$29.6K ﹤0.01% 1249
2023
Q1
$48.5K Buy
759
+114
+18% +$7.44K ﹤0.01% 1039
2022
Q4
$31.3K Buy
645
+191
+42% +$12K ﹤0.01% 1133
2022
Q3
$32K Buy
454
+204
+82% +$17.5K ﹤0.01% 1045
2022
Q2
$18K Buy
250
+197
+372% +$12.7K ﹤0.01% 1142
2022
Q1
$4K Buy
+53
New +$3.95K ﹤0.01% 1323

Other funds holding STAA

AssetMark Inc's STAA Position: Q3 2023 in Review

AssetMark Inc sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 273 shares — an estimated $14.4K sold.

AssetMark Inc first reported a position in STAA in Q1 2022 and held it in 6 quarters. The position peaked at $48.5K in Q1 2023. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

  • AssetMark Inc reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
  • AssetMark Inc sold 273 STAAR Surgical shares in Q3 2023, an estimated $14.4K.
  • AssetMark Inc first reported a position in STAAR Surgical in Q1 2022 and held it in 6 quarters.
  • AssetMark Inc's STAAR Surgical position peaked at $48.5K in Q1 2023.
  • 217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on AssetMark Inc's 13F filing for Q3 2023, filed 27 Oct 2023.